EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/06/2026
Back to search
Official data from USPTO
PULMOCIDE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
PULMOCIDE
ST13
US500000079351406Class
5, 42
Filing
79351406
Registration
7307307
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
01/08/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
09/01/2022
Registration date
02/20/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/20/2024
Last transaction
01/08/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
ANKRAH,NAAKWAMA S
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Pulmocide Limited
Representatives
Amanda M. Prose Westman, Champlin & Koehler P.A.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for the treatment of viral diseasesauto-immune and inflammatory diseasescardiovascular and pulmonary diseasesoncologic diseasesdermatologic diseasesinfectious-related diseasesrespiratory diseases; medical preparations for the treatment of viral diseasesauto-immune and inflammatory diseasescardiovascular and pulmonary diseasesoncologic diseasesdermatologic diseasesinfectious-related diseasesrespiratory diseases; fungicide; antifungal treatment preparations; preparations for treatment of lung infection; medicines for the treatment of respiratory disorders; inhalable antifungal treatment preparations
Class 42
Medical and pharmacological research services; pharmaceutical research and development; pharmaceutical product development and testing
Publications
History of USPTO decisions and trademark events.
35 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/06/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/06/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/06/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/11/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/18/2024
FIMP
FINAL DISPOSITION PROCESSED
07/18/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/21/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/20/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/05/2023
PUBO
PUBLISHED FOR OPPOSITION
12/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/15/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/15/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/30/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/27/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/27/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/27/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/27/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/27/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/27/2023
RFNT
REFUSAL PROCESSED BY IB
08/15/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/25/2023
RFRR
REFUSAL PROCESSED BY MPU
07/25/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/21/2023
CNRT
NON-FINAL ACTION WRITTEN
06/20/2023
DOCK
ASSIGNED TO EXAMINER
06/19/2023
MAFR
APPLICATION FILING RECEIPT MAILED
10/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/30/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/29/2022
Continuous trademark protection
Get notified about every new filing that threatens PULMOCIDE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.